Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
First therapy recommended for full marketing authorization in the EU for eligible patients with confirmed diagnosis of late infantile or […]